Good MorningEquities rebounded on Wednesday but it is too soon to call a bottom in the market. While the S&P 500 is moving up from the key 4,200 level the move is ahead of an important data point that could change the market's outlook. That data point is the PCE price index on Friday. The PCE Price index is expected to moderate on a sequential basis but still come in at a strong up .03% for the month and 5.3% from last year.
The risk for the market is that inflation will not moderate and there is no real reason to think it will. Not only is energy at the highest levels in a decade and driving input costs higher throughout the economy but producers and retailers are still trying to catch up with the last 12 months of inflation. If anything, the market should be prepared for a hot number and a chance the S&P 500 could break through support at 4,200 and make a move toward the 2,700 level. Featured: Get our #1 crypto pick within minutes (Ad) 
|
Markets | |
Automatic Data Processing Moves Higher On Strong Results
As great as the risks to the economy are right now, the results from Automatic Data Processing (NYSE: ADP) prove the labor market and business, in general, are doing OK. The company not only reported a stronger than expected quarter but wa... Read the Full Story |
|
From Our Partners | | Most people’s first crypto purchase is their worst one. Not because crypto is bad. Because they make the same handful of mistakes almost everyone makes. They pay too much, because they don’t know how to buy at lower prices.
Crypto Revolution, our book with a foreword by Kevin Harrington from ABC’s Shark Tank, shows you how to spot real opportunities instead of chasing hype.
Everything is digital and available the moment you claim it. | | Download Crypto Revolution now. |
|
Markets | |
Dividend investing is one of the most popular ways to invest, but one of the most common questions includes this prevailing question: “How many dividend stocks should I own?”
The answer: It depends. It depends on your dividend investing strategy, the amount of available time you have ... Read the Full Story |
|
Technology | | Document management solutions and systems provider Xerox Holdings Corporation (NYSE: XRX) stock has fallen back towards pandemic lows with its surprising disappointment for Q1 fiscal 2022 earnings report. The Company was expected to make $0.13 per share profits but ended up posting a (-$0.12) per sh... Read the Full Story |
|
From Our Partners | | The biggest IPO in history is likely just weeks away…
Anthropic, the company behind Claude AI, is rumoured to be lining up a Nasdaq debut before Thanksgiving… at a valuation of up to $2 trillion. But here’s what nobody’s talking about…
A raise of about $100 billion doesn’t just make headlines. It puts an enormous spotlight on the AI industry. And as investors rush to find the next big opportunity in artificial intelligence, some of the most interesting plays may be hiding outside traditional AI stocks. | | Click here to see my #1 pick for the Claude IPO. |
|
Technology | |
Insiders And Institutions Are Buying Xerox
Xerox (NYSE: XRX) gave a bad report for the Q1 2022 period but that bad news is being put to good use by at least one person. Carl Icahn, already a major shareholder of Xerox, made not one but two purchases of Xerox in the wake of the earnings fallout b... Read the Full Story |
|
Consumer Staples | |
Kraft Heinz Is Still A High-Yielding Value Play
Shares of Kraft Heinz (NASDAQ: KHC) wobbled in the wake of the Q1 earnings report despite better than expected results and an increase in the guidance. The results, as good as they are, are driven in large part by higher prices and only partially o... Read the Full Story |
|
From Our Partners | | After the Dot-Com Bubble burst in March 2000, the Nasdaq fell 78% over the following decade. But gold staged a historic bull run, and select miners delivered gains of 50X, 53X, 252X, and even 362X.
Garrett Goggin, CFA, CMT and founder of The Golden Portfolio, has spent over 20 years studying these market rotations, including 15 years working alongside gold analyst John Doody. He's identified four gold miners positioned for the next rotation out of AI stocks. | | See Garrett Goggin's four gold miner picks before the next rotation begins |
|
Technology | | With the major indices being slammed right down towards their lows of the year this week, there was a lot riding on Microsoft’s (NASDAQ: MSFT) earnings last night. The tech giant reported their fiscal Q3 numbers after the bell and they were, for the most part, viewed favorably by the street.
... Read the Full Story |
|
Markets | | Casino operator Las Vegas Sands (NYSE: LVS) stock has fallen toward its COVID-19 lows. The casino operator continues to see uncertainty grow in its Macao operations being affected by China’s zero-tolerance COVID policy. There is also fears of regulatory changes that further the crackdown on co... Read the Full Story |
|
Materials | |
Having some exposure to NEM stock is solid insurance for whatever comes next
Newmont Corporation (NYSE: NEM) stock continues to fall after the mining company delivered its earnings report on April 22. In fairness, the company missed slightly on both the top and bottom lines. And earnings per sha... Read the Full Story |
|
Markets | |
When pursuing dividend stocks for your investing strategy, it’s important to understand two dates in particular: the ex-dividend date, also called the ex-date, and the date of record.
The ex-dividend date is the last day in which you can buy a share of stock and receive its upcoming dividen... Read the Full Story |
|
Industrials | |
Simpson Manufacturing Co. Nails Down Its Growth Initiatives
Simpson Manufacturing Co. (NYSE: SSD) has been riding a wave of growth that can be attributed to two things; the pandemic and its CEO, Karen Colonias. The pandemic unleashed a wave of demand the company is working hard to cash in on, it... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV250, a G protein biased delta-opioid receptor agonist for the treatment of acute migraine; TRV734, a small molecule G protein biased ligand of the MOR for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is based in Chesterbrook, Pennsylvania. | | View Today's Stock Pick |
|
